More than 7,000 physicians and researchers from around the world converged in San Antonio to attend the San Antonio Breast Cancer Symposium® (SABCS®).

Elevated levels of marker associated with brain atrophy, decline in executive functions An inflammatory marker called sCD14 is related to brain atrophy, cognitive decline and dementia, according to a study of more than 4,700 participants from two large community-based heart studies. The study was published Dec. 9 in the journal Neurology. “We have strong reason […]

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. The journal Nature Medicine reported the findings Dec. 2. “This is a new class of drugs called PROTACs that target […]

Media Contact: Cliff Despres, (210) 562-6517, despres@uthscsa.edu SAN ANTONIO (Dec. 4, 2019) – As U.S. Latinos face a staggering 142% projected rise in cancer cases by 2030, UT Health San Antonio leaders gathered international cancer experts to publish a new book with innovative research and recommendations to reduce Latino cancer. The book, Advancing the Science […]

Media contact: Rosanne Fohn, (210) 567-3026, fohn@uthscsa.edu SAN ANTONIO (Dec. 3, 2019) ― More than 7,000 physicians and researchers from around the world will converge on the Henry B. Gonzalez Convention Center, 900 E. Market St., Dec. 10-14, to attend the San Antonio Breast Cancer Symposium® (SABCS®). Founded, owned and operated by UT Health San […]